On this page
Peyronie disease
This condition primarily affects men, typically in middle age, causing discomfort and potential difficulties with sexual function due to changes in penile shape and elasticity. It is thought to involve a complex interplay of genetic and environmental factors.
Overview
Peyronie disease is a disorder affecting the connective tissue of the penis. It involves the development of fibrous plaques, or scar tissue, within the tunica albuginea, which is the tough, elastic sheath surrounding the erectile tissue [PMID:33671216]. These plaques are non-cancerous and can vary in size and location. The presence of this scar tissue can prevent the affected area from stretching properly during an erection, leading to characteristic symptoms such as penile curvature, indentations, shortening, or narrowing.
The disease can progress over time, often starting with an inflammatory phase where symptoms might include pain, and then moving into a more stable, chronic phase where the pain typically subsides, but the curvature and other deformities persist. While the exact cause is not fully understood, it is generally considered a complex condition with multiple contributing factors [PMID:33671216].
Symptoms & clinical features
The symptoms of Peyronie disease can develop gradually or appear suddenly. In the early, 'acute' phase, men may experience pain during erection, which often diminishes or resolves as the condition stabilises. The most noticeable symptom is typically a noticeable bend or curvature of the penis during erection, which can be upwards, downwards, or to the side [PMID:33671216].
Other symptoms include indentations, narrowing (often described as an 'hourglass' deformity), or shortening of the penis. Some men may also feel a lump or hardened area under the skin of the penis, which is the fibrous plaque. These physical changes can lead to difficulties with sexual intercourse, psychological distress, and a reduced quality of life for those affected [PMID:33671216].
Video: Genetics 101
Affected organs
Peyronie disease primarily affects the penis. Specifically, it involves the tunica albuginea, which is a layer of connective tissue that encases the two erectile bodies (corpora cavernosa) of the penis. When healthy, this tissue is flexible and allows for expansion during erection. In Peyronie disease, fibrous plaques form within this layer, preventing normal expansion and leading to the characteristic changes in penile shape and function.
Risks & severity
The severity of Peyronie disease can vary significantly among individuals. Some men may experience mild curvature that does not significantly affect sexual function, while others may develop severe deformities that make intercourse difficult or impossible. The condition is thought to affect approximately 3-9% of men, primarily those in middle age, though it can occur at any adult age [PMID:30138927].
While the disease is not life-threatening, it can have a considerable impact on mental well-being and relationships due to its effect on sexual health and body image. Risk factors may include minor penile trauma, certain genetic predispositions, and other connective tissue disorders like Dupuytren's contracture. Smoking and diabetes have also been suggested as potential risk factors.
Genetic causes
Peyronie disease is considered a polygenic or complex disorder. This means that its development is likely influenced by a combination of multiple genes, alongside various environmental and lifestyle factors. Unlike conditions caused by a change in a single gene, there isn't one specific gene identified as the sole cause of Peyronie disease.
Research suggests that some individuals may have a genetic predisposition that makes them more susceptible to developing the condition, particularly after minor trauma to the penis. While specific causative genes are not yet established in our reference dataset, ongoing research aims to identify genetic markers that may contribute to this complex condition.
Inheritance pattern
Peyronie disease exhibits a polygenic inheritance pattern. This means that it doesn't follow a simple Mendelian inheritance model (like dominant or recessive patterns). Instead, multiple genes, each contributing a small effect, along with environmental factors, are believed to interact to influence an individual's risk of developing the condition.
While it is not directly passed down from parent to child in a predictable way, there is evidence of familial clustering, suggesting that having a close relative with Peyronie disease may slightly increase an individual's own risk. However, many people with the condition do not have a family history, highlighting the role of other contributing factors.
Diagnosis & testing
A diagnosis of Peyronie disease is typically made based on a thorough clinical examination and a review of the patient's symptoms. A doctor will usually feel the penis to locate and assess the fibrous plaques. Photographs taken by the patient during erection can be very helpful in demonstrating the degree and direction of curvature.
Sometimes, an ultrasound scan of the penis may be used to further visualise the plaques and assess blood flow, particularly if surgical intervention is being considered. Referral to a urologist, a specialist in conditions affecting the urinary and male reproductive systems, is common for confirmation of diagnosis and discussion of management options. Genetic testing is not routinely used for diagnosing Peyronie disease due to its polygenic nature. If genetic testing were required, it would typically fall under NHS R-codes related to urological disorders, if appropriate criteria were met for specialist assessment.
Management & lifestyle
Management for Peyronie disease aims to alleviate symptoms, improve penile function, and reduce distress. In the acute phase, pain management may be a focus, sometimes involving oral medications. Once the condition has stabilised (typically after 12 months, or when no further changes occur for 3-6 months), treatment options may be considered.
Non-surgical treatments include injections directly into the plaques, vacuum devices, or stretching exercises. Surgical options, such as plication (suturing to straighten the penis), grafting (removing plaques and replacing with tissue), or penile implants, are generally reserved for severe cases where curvature prevents sexual intercourse and other treatments have not been effective. The choice of treatment depends on the severity of the condition, patient preferences, and the stage of the disease. Patients are typically managed by urology specialists within the NHS, who can provide tailored advice and discuss suitable interventions.
UK care pathway
In the UK, individuals with suspected Peyronie disease would typically first consult their GP. The GP may then refer to a specialist, usually a urologist, for further assessment and diagnosis. Clinical genetics services are generally not involved in the direct diagnosis or management of Peyronie disease due to its complex, polygenic nature and the absence of a single causative gene. However, individuals may still access genetic counselling if they have concerns about familial patterns or other related connective tissue issues. Care pathways for urological conditions are well-established within the NHS.
Frequently asked questions
Is Peyronie disease hereditary?
Peyronie disease is not inherited in a simple manner like some single-gene disorders. It is considered a polygenic condition, meaning multiple genes and environmental factors contribute to its development. While there can be a family tendency, it doesn't follow a clear inheritance pattern.
Can Peyronie disease get worse over time?
Yes, Peyronie disease often progresses in two phases. Initially, there can be an acute inflammatory phase with pain and developing curvature. This is usually followed by a chronic, stable phase where the pain typically subsides, but the curvature or deformities may become permanent or worsen before stabilising. It is important to monitor symptoms and discuss them with a healthcare professional.
Is surgery the only treatment for Peyronie disease?
No, surgery is not the only treatment option. There are various non-surgical approaches, including oral medications, injections directly into the plaques, and mechanical therapies like vacuum devices. Surgery is generally considered for more severe cases when other treatments have not been successful and the curvature significantly affects sexual function.
Who should I see if I think I have Peyronie disease?
If you suspect you have Peyronie disease, you should first consult your General Practitioner (GP). Your GP can provide an initial assessment and, if appropriate, refer you to a urologist, who specialises in conditions affecting the male reproductive and urinary systems, for further diagnosis and management.
What is the likelihood of developing Peyronie disease?
Peyronie disease is estimated to affect around 3-9% of men, typically in middle age, though it can occur at any point in adulthood. This means it is not a rare condition. The exact risk for an individual depends on a combination of genetic and environmental factors.